e-Pakiet insulinooporność — Insulin Resistance Panel

Metabolic panel with 10 markers specifically designed to detect insulin resistance and pre-diabetes — fasting glucose, fasting insulin, HOMA-IR calculation, HbA1c, full lipidogram, ALT, and TSH. At 329 PLN (~76 EUR) with blood draw included. Identifies metabolic dysfunction years before diabetes diagnosis.

Insulin resistance is the pathophysiological driver of type 2 diabetes, metabolic syndrome, and polycystic ovary syndrome (PCOS). This panel delivers the biomarkers required to detect and quantify insulin resistance at its earliest, most modifiable stage — often 5-10 years before fasting glucose crosses the diabetic threshold. The central combination is fasting glucose, fasting insulin, and HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). HOMA-IR is calculated as (fasting glucose x fasting insulin) / 405 (in conventional units). A HOMA-IR above 2.5 indicates insulin resistance; above 5.0 signals significant metabolic dysfunction. This calculation exposes metabolic problems that fasting glucose alone cannot — a patient may maintain normal fasting glucose (below 5.6 mmol/L) while producing markedly elevated insulin levels, indicating that the pancreas is working overtime to keep glucose in range. This compensated state eventually fails, driving the progression from insulin resistance through impaired fasting glucose and impaired glucose tolerance to frank type 2 diabetes. HbA1c provides a 2-3 month average of blood glucose. Values between 5.7-6.4% (39-47 mmol/mol) define pre-diabetes, where structured lifestyle intervention (weight management, regular exercise, dietary modification) reduces progression to diabetes by 58% — one of the most impactful preventive interventions in modern medicine. HbA1c above 6.5% is diagnostic of diabetes. The full lipidogram is essential because dyslipidaemia is a hallmark of the insulin-resistant state. The characteristic lipid profile features elevated triglycerides, low HDL cholesterol, and small dense LDL particles — a pattern that can exist even when total cholesterol and LDL appear reassuringly normal. A triglyceride-to-HDL ratio above 3.0 (in mg/dL units) is a straightforward but powerful surrogate marker of insulin resistance. ALT (alanine aminotransferase) screens for non-alcoholic fatty liver disease (NAFLD), which is present in approximately 70-80% of insulin-resistant individuals. NAFLD can progress through steatohepatitis (NASH) to cirrhosis and hepatocellular carcinoma. TSH screens for hypothyroidism, which mimics or worsens metabolic symptoms including weight gain, fatigue, and dyslipidaemia. At 329 PLN with blood draw included, this panel provides a thorough metabolic assessment. A German endocrinologist would typically charge 200-400 EUR for equivalent testing. The panel is particularly relevant for patients with PCOS, family history of type 2 diabetes, central obesity, or unexplained fatigue and weight gain. Warsaw's central location in Europe — reachable from Berlin by train in roughly 5.5 hours or by short flights from across the continent — makes it a practical base for affordable metabolic diagnostics.